🇺🇸 FDA
Pipeline program

Diamyd

Phase 2 small_molecule active

Quick answer

Diamyd for Latent Autoimmune Diabetes in Adults (LADA) is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Latent Autoimmune Diabetes in Adults (LADA)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials